News
Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on June 1, 2025 the Company granted inducement awards to ...
Investing.com -- Shares of Incyte (NASDAQ: INCY) climbed 7% today after the biopharmaceutical company announced that multiple ...
InvestorsHub on MSN4d
Incyte Shares Jump After EHA Conference Accepts Key Research PresentationsIncyte Corporation (NASDAQ:INCY) saw its stock surge 7% after the company announced that multiple research presentations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback